ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
杭州德適生物科技股份有限公司(臨時代碼)
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
- -
香港流通股本:
- -
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
市銷率:
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
醫學影像大模型第一股來了?德適生物港股IPO獲證監會備案
市场资讯
·
01/07
【新股IPO】杭州德適生物科技股份有限公司 - B向港交所主板提交上市申請
金吾财讯
·
01/07
新股消息 | 德適生物港股IPO及境內未上市股份「全流通」獲中國證監會備案
智通财经
·
01/05
新股消息 | 德適生物港股IPO招股書失效
智通财经
·
2025/12/29
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/91016"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"91016","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91016\",,,,,undefined,":{"symbol":"91016","market":"HK","secType":"STK","nameCN":"杭州德適生物科技股份有限公司(臨時代碼)","latestPrice":0,"timestamp":1770796800000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"02-11 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770859800000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1770773400000,1770782400000],[1770786000000,1770796800000]],"volumeRatio":0,"lotSize":100,"spreadScale":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91016\",,,,,undefined,":{"symbol":"91016","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/91016\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"91016\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"91016\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"91016\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601878911","title":"醫學影像大模型第一股來了?德適生物港股IPO獲證監會備案","url":"https://stock-news.laohu8.com/highlight/detail?id=2601878911","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601878911?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 15:00","pubTimestamp":1767769200,"startTime":"0","endTime":"0","summary":" 2026年1月5日,中国证监会发布备案通知,杭州德适生物科技股份有限公司正式获批境外发行上市及境内未上市股份“全流通”。这意味着,这家深耕医学影像人工智能、软件研发与高端医疗装备的企业,即将登陆港交所,有望成为全球首家以“医学影像大模型”为核心资产的上市公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-01-07/doc-inhfnktr4756891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02251","BK1189","91016"],"gpt_icon":0},{"id":"2601819190","title":"【新股IPO】杭州德適生物科技股份有限公司 - B向港交所主板提交上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2601819190","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601819190?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 00:01","pubTimestamp":1767715302,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所1月6日披露,杭州德适生物科技股份有限公司 - B向港交所主板提交上市申请,华泰国际为独家保荐人。公司成立于2016年,是一家专注于开发医学影像产品及服务的医疗器械公司。公司核心产品AI AutoVision是一款染色体核型辅助诊断软件,专为执行染色体核型智能分析而设计。AI AutoVision于2025年5月获国家药监局认定为“三类创新医疗器械”,可享受加速监管审批流程。同月,公司向国家药监局提交第三类医疗器械注册申请。","market":"sh","thumbnail":"https://static.szfiu.com/news/20220324/MzRhMTE1MTUwMjgzODI3Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/MzRhMTE1MTUwMjgzODI3Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972700","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEXmain","91016"],"gpt_icon":0},{"id":"2601866678","title":"新股消息 | 德適生物港股IPO及境內未上市股份「全流通」獲中國證監會備案","url":"https://stock-news.laohu8.com/highlight/detail?id=2601866678","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601866678?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 20:01","pubTimestamp":1767614473,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,1月5日,中国证监会国际合作司发布《关于杭州德适生物科技股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书》。该公司27名股东拟将所持合计8088万股境内未上市股份转为境外上市股份,并在香港联合交易所上市流通。据招股书披露,德适生物一直专注医学影像AI行业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["91016"],"gpt_icon":0},{"id":"2595784449","title":"新股消息 | 德適生物港股IPO招股書失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2595784449","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595784449?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 19:11","pubTimestamp":1767006662,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,杭州德适生物科技股份有限公司(简称:德适生物)于6月29日递交的港股招股书满6个月,于12月29日失效,递表时华泰国际为独家保荐人。招股书显示,根据弗若斯特沙利文资料,德适生物自主研发的iMedImageTM是世界上参数规模最大的通用型医学影像基座模型,已成功实现商业化,而且被认定为世界上首个商业化跨模态医学影像基座模型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["91016"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/91016\",params:#limit:6,delay:false,,,undefined,":[]}}